StockData
Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc. (CABA) stock

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.02−0.09 (-8.11%)

Close on Nov 17, 2026Market cap $172.94MP/E –Yield –

Cabaletta Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cabaletta Bio's market cap was $300.43M on Apr 30, 2026, against $116.75M a year earlier. Over the last 5 years it ranged from $18.86M to $1.09B, with a median of $261.56M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Apr 30, 2026$300.43M+42.5%
2025Dec 31, 2025$210.82M+90.1%
2024Dec 31, 2024$110.89M-88.3%
2023Dec 29, 2023$945.69M+252.4%
2022Dec 30, 2022$268.38M+155.3%
2021Dec 31, 2021$105.10M-65.0%
2020Dec 31, 2020$300.21M+458.4%
2019Dec 31, 2019$53.76M–

More Cabaletta Bio figures

See a number that looks wrong?